Tapewire

Nasdaq · USD

FENC

FENNEC PHARMACEUTICALS INC.

Export transactions ↓
Tapewire entity
5601
SEC CIK
0001211583
Parsed reports
281

Last 12 months

Inside the activity.

0 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202502
Jan 202601
Feb 202601
Mar 202601
Apr 202601
May 202602
Jun 202601
Jul 202601
Aug 202603
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 03, 2025 Filed Jul 7, 2025 20:30 UTC
Raykov RostyDirector
SaleCommon shares 10,000 $8.61 $86,100.00
Disclosure

SEC source: 0001415889-25-019414 · form4-07072025_040701.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,670

F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024.

Read SEC document
June 30, 2025 Filed Jul 1, 2025 22:57 UTC
Raykov RostyDirector
GrantCommon shares 5,208 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-018800 · form4-07012025_100737.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,670

F1 · security: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.

Read SEC document
June 30, 2025 Filed Jul 1, 2025 22:56 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantCommon shares 2,431 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-018798 · form4-07012025_100726.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,382

F1 · security: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:20 UTC
Raykov RostyDirector
SaleCommon shares 10,000 $7.78 $77,800.00
Disclosure

SEC source: 0001415889-25-015988 · form4-06062025_040601.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,462

F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 20:20 UTC
Islam KhalidDirector
GrantStock Option · Derivative 25,000 $7.88 Strike: $7.88 $197,000.00
Disclosure

SEC source: 0001415889-25-015586 · form4-06042025_040601.xml · derivative · entry 1

Islam Khalid · CIK 0001701858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Shares · 25,000 shares

Expires 2035-06-03

F1 · security: On June 3, 2025, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

F2 · derivative.exercise_date: The option is 100% vested on date of grant.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 20:20 UTC GrantStock Option · Derivative 20,000 $7.88 Strike: $7.88 $157,600.00
Disclosure

SEC source: 0001415889-25-015587 · form4-06042025_040604.xml · derivative · entry 1

RALLIS CHRIS A · CIK 0001185945 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,533

Underlying: Common shares · 20,000 shares

Expires 2035-06-03

F1 · security: On June 3, 2025, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

F2 · derivative.exercise_date: The option is 100% vested on date of grant.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 20:20 UTC
Cook Jodi ADirector
GrantStock Options · Derivative 20,000 $7.88 Strike: $7.88 $157,600.00
Disclosure

SEC source: 0001415889-25-015589 · form4-06042025_040611.xml · derivative · entry 1

Cook Jodi A · CIK 0001791004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Shares · 20,000 shares

Expires 2035-06-03

F1 · security: On June 3, 2025, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

F2 · derivative.exercise_date: The option is 100% vested on date of grant.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 20:20 UTC GrantStock Option · Derivative 20,000 $7.88 Strike: $7.88 $157,600.00
Disclosure

SEC source: 0001415889-25-015588 · form4-06042025_040607.xml · derivative · entry 1

Brughera Marco Maria · CIK 0001589776 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,545

Underlying: Common shares · 20,000 shares

Expires 2035-06-03

F1 · security: On June 3, 2025, Marco Brughera was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

F2 · derivative.exercise_date: The option is 100% vested on date of grant.

Read SEC document
May 31, 2025 Filed Jun 2, 2025 21:02 UTC
Raykov RostyDirector
GrantCommon shares 5,208 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-015218 · form4-06022025_090638.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,462

F1 · security: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.

Read SEC document
May 31, 2025 Filed Jun 2, 2025 21:01 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantCommon shares 2,431 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-015213 · form4-06022025_090644.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,951

F1 · security: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.

Read SEC document
May 22, 2025 Filed May 23, 2025 20:20 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
Exercise / conversionStock Options · Derivative 8,220 $5.10 Strike: $5.10 $41,922.00
Disclosure

SEC source: 0001415889-25-014467 · form4-05232025_040501.xml · derivative · entry 2

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 850,751

Underlying: Options · 8,220 shares

Expires 2027-06-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.

Read SEC document
May 22, 2025 Filed May 23, 2025 20:20 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
Exercise / conversionCommon shares 8,220 $5.10 $41,922.00
Disclosure

SEC source: 0001415889-25-014467 · form4-05232025_040501.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.

Read SEC document
May 19, 2025 Filed May 19, 2025 21:42 UTC
Hackman Jeffrey S.Director · Chief Executive Officer
PurchaseCommon Shares 13,965 $6.99 $97,615.35
Disclosure

SEC source: 0001415889-25-013673 · form4-05192025_090517.xml · nonDerivative · entry 2

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

F1 · security: Transaction Code P - Open market or private purchase of non-derivative or derivative security

Read SEC document
May 16, 2025 Filed May 19, 2025 20:30 UTC
Raykov RostyDirector
SaleCommon shares 16,667 $6.78 $113,002.26
Disclosure

SEC source: 0001415889-25-013642 · form4-05192025_040516.xml · nonDerivative · entry 2

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,254

F2 · security: The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain restricted stock units.

Read SEC document
May 16, 2025 Filed May 19, 2025 20:30 UTC
Raykov RostyDirector
GrantCommon shares 33,334 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-013642 · form4-05192025_040516.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,921

F1 · security: Represents shares released from restriction from shares awarded 5-16-2024.

Read SEC document
May 16, 2025 Filed May 19, 2025 20:30 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantCommon shares 16,667 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-013641 · form4-05192025_040513.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,300

F1 · security: Represents shares released from restriction from shares awarded 5-16-2024.

Read SEC document
May 16, 2025 Filed May 19, 2025 21:42 UTC
Hackman Jeffrey S.Director · Chief Executive Officer
PurchaseCommon Shares 1,035 $6.75 $6,986.25
Disclosure

SEC source: 0001415889-25-013673 · form4-05192025_090517.xml · nonDerivative · entry 1

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,035

F1 · security: Transaction Code P - Open market or private purchase of non-derivative or derivative security

Read SEC document
May 05, 2025 Filed May 5, 2025 22:23 UTC
Raykov RostyDirector
SaleCommon shares 10,000 $6.31 $63,100.00
Disclosure

SEC source: 0001415889-25-012016 · form4-05052025_100512.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,587

F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024.

Read SEC document
April 30, 2025 Filed May 1, 2025 22:03 UTC
Raykov RostyDirector
GrantCommon shares 2,431 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011686 · form4-05012025_100501.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,587

F1 · security: Represents release of restriction from shares awarded 3-31-2023

Read SEC document
April 30, 2025 Filed May 1, 2025 22:03 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantCommon shares 1,042 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011688 · form4-05012025_100543.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,633

F1 · security: Represents shares released from restriction from shares awarded 3-31-2023.

Read SEC document
April 11, 2025 Filed Apr 11, 2025 20:31 UTC Exercise / conversionCommon Shares · Derivative 2,173 $2.30 Strike: $2.30 $4,997.90
Disclosure

SEC source: 0001415889-25-010574 · form4-04112025_080457.xml · derivative · entry 3

RALLIS CHRIS A · CIK 0001185945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 180,533

Underlying: Options · 2,173 shares

Expires 2025-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.

Read SEC document
April 11, 2025 Filed Apr 11, 2025 20:31 UTC SaleCommon Shares 1,409 $4.95 $6,974.55
Disclosure

SEC source: 0001415889-25-010574 · form4-04112025_080457.xml · nonDerivative · entry 2

RALLIS CHRIS A · CIK 0001185945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,784

F2 · security: Shares sold to satisfy tax obligation on option exercise.

Read SEC document
April 11, 2025 Filed Apr 11, 2025 20:31 UTC Exercise / conversionCommon Shares 2,173 $2.30 $4,997.90
Disclosure

SEC source: 0001415889-25-010574 · form4-04112025_080457.xml · nonDerivative · entry 1

RALLIS CHRIS A · CIK 0001185945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,193

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: . Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.

Read SEC document
April 04, 2025 Filed Apr 4, 2025 23:29 UTC
Raykov RostyDirector
SaleCommon shares 10,000 $5.25 $52,500.00
Disclosure

SEC source: 0001415889-25-010260 · form4-04042025_110426.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,156

F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024.

Read SEC document
March 31, 2025 Filed Apr 1, 2025 21:18 UTC
Raykov RostyDirector
GrantCommon shares 2,431 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-009399 · form4-04012025_090439.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,156

F1 · security: Represents release of restriction from shares awarded 3-31-2023

Read SEC document
March 31, 2025 Filed Apr 1, 2025 21:17 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantCommon shares 1,042 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-009397 · form4-04012025_090441.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,591

F1 · security: Represents shares released from restriction from shares awarded 3-31-2023.

Read SEC document
March 28, 2025 Filed Apr 3, 2025 23:15 UTC
Sayad Pierre SargisChief Medical Officer
GrantRestricted Share Unit · Derivative 10,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-010069 · form4-04032025_110438.xml · derivative · entry 1

Sayad Pierre Sargis · CIK 0002043395 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Shares · 10,000 shares

Expires 2035-03-28

F1 · security: On March 28, 2025, Pierre Sayad was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.

F2 · derivative.exercise_date: One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.

Read SEC document
March 28, 2025 Filed Apr 3, 2025 22:11 UTC
Evans Terry LChief Commercial Officer
GrantRestricted Share Unit · Derivative 10,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-010055 · form4-04032025_100449.xml · derivative · entry 1

Evans Terry L · CIK 0002043317 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Shares · 10,000 shares

Expires 2035-03-28

F1 · security: On March 28, 2025,Terry Evans was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.

F2 · derivative.exercise_date: One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.

Read SEC document
March 28, 2025 Filed Apr 3, 2025 23:16 UTC Amendment
Cioffi Christiana MarieChief Strategy Officer
GrantRestricted Share Unit · Derivative 10,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-010071 · form4a-04032025_110424.xml · derivative · entry 1

Cioffi Christiana Marie · CIK 0002043411 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Shares · 10,000 shares

Expires 2035-03-28

F1 · security: On March 28, 2025, Christiana Cioffi was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.

F2 · derivative.exercise_date: One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.

Read SEC document
March 28, 2025 Filed Apr 3, 2025 23:14 UTC Amendment
Evans Terry LChief Commercial Officer
GrantRestricted Share Unit · Derivative 10,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-010067 · form4a-04032025_110435.xml · derivative · entry 1

Evans Terry L · CIK 0002043317 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Shares · 10,000 shares

Expires 2035-03-28

F1 · security: On March 28, 2025,Terry Evans was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.

F2 · derivative.exercise_date: One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.

Read SEC document
March 28, 2025 Filed Apr 3, 2025 22:10 UTC
Cioffi Christiana MarieChief Strategy Officer
GrantRestricted Share Unit · Derivative 10,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-010053 · form4-04032025_100448.xml · derivative · entry 1

Cioffi Christiana Marie · CIK 0002043411 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Shares · 10,000 shares

Expires 2035-03-28

F1 · security: On March 28, 2025, Christiana Cioffi was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.

F2 · derivative.exercise_date: One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.

Read SEC document
March 28, 2025 Filed Apr 3, 2025 23:12 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantStock Options · Derivative 50,000 $0.00 Strike: $6.50 $0.00
Disclosure

SEC source: 0001415889-25-010063 · form4-04032025_110450.xml · derivative · entry 2

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 877,722

Underlying: Options · 50,000 shares

Expires 2035-03-28

F3 · security: On March 28, 2025, Robert Andrade was granted incentive stock options to purchase 50,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F4 · derivative.exercise_date: One-third of the shares subject to this option may be exercised as of March 28, 2026 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028, 100% of the total number of shares subject to this option shall be vested.

Read SEC document
March 28, 2025 Filed Apr 3, 2025 23:12 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantRestricted Share Unit · Derivative 75,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-010063 · form4-04032025_110450.xml · derivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 827,722

Underlying: Common Shares · 75,000 shares

Expires 2035-03-28

F1 · security: On March 28, 2025, Robert Andrade was awarded restricted share units to acquire 75,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan

F2 · derivative.exercise_date: One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.

Read SEC document
March 28, 2025 Filed Apr 3, 2025 23:13 UTC Amendment
Hackman Jeffrey S.Director · Chief Executive Officer
GrantStock Options · Derivative 50,000 $0.00 Strike: $6.50 $0.00
Disclosure

SEC source: 0001415889-25-010065 · form4a-04032025_110440.xml · derivative · entry 2

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 525,000

Underlying: Common Shares · 50,000 shares

Expires 2035-03-28

F3 · security: On March 28, 2025, Jeffrey Hackman was granted incentive stock options to purchase 50,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F4 · derivative.exercise_date: One-third of the shares subject to this option may be exercised as of March 28, 2026 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028, 100% of the total number of shares subject to this option shall be vested

Read SEC document
March 28, 2025 Filed Apr 3, 2025 23:13 UTC Amendment
Hackman Jeffrey S.Director · Chief Executive Officer
GrantRestricted Share Unit · Derivative 75,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-010065 · form4a-04032025_110440.xml · derivative · entry 1

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 475,000

Underlying: Common Shares · 75,000 shares

Expires 2035-03-28

F1 · security: On March 28, 2025, Jeffrey Hackman was awarded restricted share units to acquire 75,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan

F2 · derivative.exercise_date: One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.

Read SEC document
March 28, 2025 Filed Apr 3, 2025 22:12 UTC
Hackman Jeffrey S.Director · Chief Executive Officer
GrantStock Options · Derivative 50,000 $0.00 Strike: $6.50 $0.00
Disclosure

SEC source: 0001415889-25-010057 · form4-04032025_100450.xml · derivative · entry 2

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Shares · 50,000 shares

Expires 2035-03-28

F3 · security: On March 28, 2025, Jeffrey Hackman was granted incentive stock options to purchase 50,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F4 · derivative.exercise_date: One-third of the shares subject to this option may be exercised as of March 28, 2026 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028, 100% of the total number of shares subject to this option shall be vested

Read SEC document
March 28, 2025 Filed Apr 3, 2025 22:12 UTC
Hackman Jeffrey S.Director · Chief Executive Officer
GrantRestricted Share Unit · Derivative 75,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001415889-25-010057 · form4-04032025_100450.xml · derivative · entry 1

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Shares · 75,000 shares

Expires 2035-03-28

F1 · security: On March 28, 2025, Jeffrey Hackman was awarded restricted share units to acquire 75,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan

F2 · derivative.exercise_date: One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 22:32 UTC
Raykov RostyDirector
SaleCommon shares 10,000 $6.79 $67,900.00
Disclosure

SEC source: 0001415889-25-007264 · form4-03062025_100312.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,725

F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024.

Read SEC document
February 28, 2025 Filed Feb 28, 2025 23:51 UTC
Raykov RostyDirector
GrantCommon shares 2,431 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006063 · form4-02282025_110249.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,725

F1 · security: Represents release of restriction from shares awarded 3-31-2023

Read SEC document
February 28, 2025 Filed Feb 28, 2025 23:53 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantCommon shares 1,042 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006066 · form4-02282025_110218.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,549

F1 · security: Represents shares released from restriction from shares awarded 3-31-2023.

Read SEC document
February 14, 2025 Filed Feb 14, 2025 23:13 UTC Exercise / conversionCommon Shares · Derivative 1,992 $2.51 Strike: $2.51 $4,999.92
Disclosure

SEC source: 0001415889-25-004249 · form4-02142025_110245.xml · derivative · entry 3

RALLIS CHRIS A · CIK 0001185945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 182,706

Underlying: Options · 1,992 shares

Expires 2025-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.

Read SEC document
February 14, 2025 Filed Feb 14, 2025 23:13 UTC SaleCommon Shares 1,186 $6.82 $8,088.52
Disclosure

SEC source: 0001415889-25-004249 · form4-02142025_110245.xml · nonDerivative · entry 2

RALLIS CHRIS A · CIK 0001185945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,020

F2 · security: Shares sold to satisfy tax obligation on option exercise.

Read SEC document
February 14, 2025 Filed Feb 14, 2025 23:13 UTC Exercise / conversionCommon Shares 1,992 $2.51 $4,999.92
Disclosure

SEC source: 0001415889-25-004249 · form4-02142025_110245.xml · nonDerivative · entry 1

RALLIS CHRIS A · CIK 0001185945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.

Read SEC document
February 05, 2025 Filed Feb 6, 2025 01:24 UTC
Raykov RostyDirector
SaleCommon shares 10,000 $6.66 $66,600.00
Disclosure

SEC source: 0001415889-25-003169 · form4-02062025_010234.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,294

F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024.

Read SEC document
January 31, 2025 Filed Feb 3, 2025 22:50 UTC
Raykov RostyDirector
GrantCommon shares 2,431 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002787 · form4-02032025_100211.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,294

F1 · security: Represents release of restriction from shares awarded 3-31-2023

Read SEC document
January 31, 2025 Filed Feb 3, 2025 22:48 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantCommon shares 1,042 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002785 · form4-02032025_100225.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,507

F1 · security: Represents shares released from restriction from shares awarded 3-31-2023.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:15 UTC
Raykov RostyDirector
SaleCommon shares 7,569 $6.08 $46,019.52
Disclosure

SEC source: 0001415889-25-001014 · form4-01072025_050102.xml · nonDerivative · entry 2

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 83,863

F2 · security: Shares acquired through the exercise of an option contract with strike price of $2.36 on August 13, 2020.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:15 UTC
Raykov RostyDirector
SaleCommon shares 2,431 $6.08 $14,780.48
Disclosure

SEC source: 0001415889-25-001014 · form4-01072025_050102.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,432

F1 · security: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 22:46 UTC
Raykov RostyDirector
GrantCommon shares 2,431 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-000604 · form4-01032025_100101.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,863

F1 · security: Represents release of restriction from shares awarded 3-31-2023

Read SEC document
December 31, 2024 Filed Jan 3, 2025 22:47 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantCommon shares 1,042 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-000606 · form4-01032025_100102.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,465

F1 · security: Represents shares released from restriction from shares awarded 3-31-2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.